Asset Details
Do you wish to reserve the book?
The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway
Do you wish to request the book?
The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway
2016
Overview
Glioblastoma is the most common and aggressive form of intrinsic brain tumor. Transforming growth factor (TGF)-β represents a central mediator of the malignant phenotype of these tumors by promoting invasiveness and angiogenesis, maintaining tumor cell stemness and inducing profound immunosuppression. Integrins, which are highly expressed in glioma cells, interact with the TGF-β pathway. Furthermore, a link has been described between activity of the transcription factor aryl hydrocarbon receptor (AhR) and TGF-β expression. Here we demonstrate that integrin inhibition, using αv, β3 or β5 neutralizing antibodies, RNA interference-mediated integrin gene silencing or pharmacological inhibition by the cyclic RGD peptide EMD 121974 (cilengitide) or the non-peptidic molecule GLPG0187, inhibits AhR activity. These effects are independent of cell detachment or cell density. While AhR mRNA expression was not affected by integrin inhibition, AhR total and nuclear protein levels were reduced, suggesting that integrin inhibition-mediated regulation of AhR may occur at a post-transcriptional level. AhR-null astrocytes, AhR-null hepatocytes or glioblastoma cells with a transiently silenced AhR gene showed reduced sensitivity to integrin inhibition-mediated alterations in TGF-β signaling, indicating that AhR mediates integrin control of the TGF-β pathway. Accordingly, there was a significant correlation of αv integrin levels with nuclear AhR and pSmad2 levels as determined by immunohistochemistry in human glioblastoma
in vivo
. In summary, this study identifies a signaling network comprising integrins, AhR and TGF-β and validates integrin inhibition as a promising strategy not only to inhibit angiogenesis, but also to block AhR- and TGF-β-controlled features of malignancy in human glioblastoma.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
/ 13/100
/ 13/106
/ 13/109
/ 13/31
/ 13/51
/ 13/89
/ 14/1
/ 14/19
/ 38/77
/ 82/80
/ AhR gene
/ Animals
/ Antibodies, Neutralizing - pharmacology
/ Brain Neoplasms - metabolism
/ Glioma
/ Humans
/ Integrins - antagonists & inhibitors
/ Kinases
/ Medicine
/ Naphthyridines - pharmacology
/ Oncology
/ Peptides, Cyclic - pharmacology
/ Receptors, Aryl Hydrocarbon - antagonists & inhibitors
/ Receptors, Aryl Hydrocarbon - genetics
/ Receptors, Aryl Hydrocarbon - metabolism
/ Reverse Transcriptase Polymerase Chain Reaction
/ Transforming Growth Factor beta - genetics
